JPMorgan Chase & Co. Buys 184,917 Shares of HealthStream, Inc. $HSTM

JPMorgan Chase & Co. lifted its stake in shares of HealthStream, Inc. (NASDAQ:HSTM) by 74.6% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 432,822 shares of the technology company’s stock after acquiring an additional 184,917 shares during the period. JPMorgan Chase & Co. owned 1.46% of HealthStream worth $12,223,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of HSTM. Tower Research Capital LLC TRC raised its holdings in shares of HealthStream by 241.4% during the second quarter. Tower Research Capital LLC TRC now owns 2,407 shares of the technology company’s stock valued at $67,000 after purchasing an additional 1,702 shares during the period. State of Wyoming bought a new stake in HealthStream during the second quarter worth $106,000. PNC Financial Services Group Inc. grew its position in HealthStream by 149.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 4,760 shares of the technology company’s stock worth $134,000 after purchasing an additional 2,854 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its position in shares of HealthStream by 14.9% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 5,843 shares of the technology company’s stock valued at $162,000 after purchasing an additional 758 shares during the last quarter. Finally, Arizona State Retirement System bought a new stake in shares of HealthStream in the 3rd quarter worth approximately $203,000. 69.58% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Weiss Ratings cut shares of HealthStream from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, February 18th. Canaccord Genuity Group set a $25.00 target price on shares of HealthStream in a research note on Thursday, January 8th. Wall Street Zen downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Citigroup reissued a “market perform” rating on shares of HealthStream in a report on Tuesday, January 6th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $25.00.

HealthStream Stock Performance

Shares of HealthStream stock opened at $21.89 on Friday. HealthStream, Inc. has a 52-week low of $19.50 and a 52-week high of $34.13. The company’s 50 day moving average price is $21.58 and its 200-day moving average price is $24.66. The stock has a market capitalization of $649.48 million, a price-to-earnings ratio of 35.89, a P/E/G ratio of 2.43 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings results on Monday, February 23rd. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a net margin of 6.03% and a return on equity of 5.98%. The business had revenue of $79.71 million for the quarter, compared to analyst estimates of $76.21 million. As a group, equities research analysts forecast that HealthStream, Inc. will post 0.63 earnings per share for the current fiscal year.

HealthStream Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 20th. Investors of record on Monday, March 9th will be issued a dividend of $0.035 per share. The ex-dividend date is Monday, March 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.6%. This is a boost from HealthStream’s previous quarterly dividend of $0.03. HealthStream’s dividend payout ratio (DPR) is presently 19.67%.

HealthStream announced that its board has approved a stock buyback program on Tuesday, November 11th that authorizes the company to repurchase $10.00 million in shares. This repurchase authorization authorizes the technology company to purchase up to 1.3% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling

In other HealthStream news, EVP Kevin P. O’hara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $24.26, for a total transaction of $48,520.00. Following the completion of the transaction, the executive vice president owned 16,373 shares of the company’s stock, valued at $397,208.98. This represents a 10.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CTO Jeff Cunningham sold 2,100 shares of HealthStream stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $24.09, for a total value of $50,589.00. Following the completion of the sale, the chief technology officer owned 31,489 shares in the company, valued at approximately $758,570.01. This represents a 6.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 20.50% of the company’s stock.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.